Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Streptococcus-based
1.2.3 Legionella-based
1.2.4 Chlamydophila-based
1.2.5 Viral Pneumonia-based
1.2.6 Mycoplasma Pneumonia-based
1.3 Market by Application
1.3.1 Global Pneumonia Diagnostic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Diagnostic Market Perspective (2018-2033)
2.2 Pneumonia Diagnostic Growth Trends by Region
2.2.1 Global Pneumonia Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pneumonia Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Pneumonia Diagnostic Forecasted Market Size by Region (2024-2033)
2.3 Pneumonia Diagnostic Market Dynamics
2.3.1 Pneumonia Diagnostic Industry Trends
2.3.2 Pneumonia Diagnostic Market Drivers
2.3.3 Pneumonia Diagnostic Market Challenges
2.3.4 Pneumonia Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Diagnostic Players by Revenue
3.1.1 Global Top Pneumonia Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Pneumonia Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Pneumonia Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pneumonia Diagnostic Revenue
3.4 Global Pneumonia Diagnostic Market Concentration Ratio
3.4.1 Global Pneumonia Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Diagnostic Revenue in 2022
3.5 Pneumonia Diagnostic Key Players Head office and Area Served
3.6 Key Players Pneumonia Diagnostic Product Solution and Service
3.7 Date of Enter into Pneumonia Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumonia Diagnostic Breakdown Data by Type
4.1 Global Pneumonia Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Pneumonia Diagnostic Forecasted Market Size by Type (2024-2033)
5 Pneumonia Diagnostic Breakdown Data by Application
5.1 Global Pneumonia Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Pneumonia Diagnostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pneumonia Diagnostic Market Size (2018-2033)
6.2 North America Pneumonia Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Pneumonia Diagnostic Market Size by Country (2018-2023)
6.4 North America Pneumonia Diagnostic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pneumonia Diagnostic Market Size (2018-2033)
7.2 Europe Pneumonia Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Pneumonia Diagnostic Market Size by Country (2018-2023)
7.4 Europe Pneumonia Diagnostic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pneumonia Diagnostic Market Size (2018-2033)
8.2 Asia-Pacific Pneumonia Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Pneumonia Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Pneumonia Diagnostic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pneumonia Diagnostic Market Size (2018-2033)
9.2 Latin America Pneumonia Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Pneumonia Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Pneumonia Diagnostic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pneumonia Diagnostic Market Size (2018-2033)
10.2 Middle East & Africa Pneumonia Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Pneumonia Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Pneumonia Diagnostic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Pneumonia Diagnostic Introduction
11.1.4 Abbott Revenue in Pneumonia Diagnostic Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Glaxo Smith Kline
11.2.1 Glaxo Smith Kline Company Detail
11.2.2 Glaxo Smith Kline Business Overview
11.2.3 Glaxo Smith Kline Pneumonia Diagnostic Introduction
11.2.4 Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2018-2023)
11.2.5 Glaxo Smith Kline Recent Development
11.3 Affymetrix
11.3.1 Affymetrix Company Detail
11.3.2 Affymetrix Business Overview
11.3.3 Affymetrix Pneumonia Diagnostic Introduction
11.3.4 Affymetrix Revenue in Pneumonia Diagnostic Business (2018-2023)
11.3.5 Affymetrix Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Detail
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Pneumonia Diagnostic Introduction
11.4.4 Becton Dickinson Revenue in Pneumonia Diagnostic Business (2018-2023)
11.4.5 Becton Dickinson Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Detail
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Pneumonia Diagnostic Introduction
11.5.4 BioMerieux Revenue in Pneumonia Diagnostic Business (2018-2023)
11.5.5 BioMerieux Recent Development
11.6 Cepheid
11.6.1 Cepheid Company Detail
11.6.2 Cepheid Business Overview
11.6.3 Cepheid Pneumonia Diagnostic Introduction
11.6.4 Cepheid Revenue in Pneumonia Diagnostic Business (2018-2023)
11.6.5 Cepheid Recent Development
11.7 Diamedix/Erba
11.7.1 Diamedix/Erba Company Detail
11.7.2 Diamedix/Erba Business Overview
11.7.3 Diamedix/Erba Pneumonia Diagnostic Introduction
11.7.4 Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2018-2023)
11.7.5 Diamedix/Erba Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pneumonia Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Streptococcus-based
Table 3. Key Players of Legionella-based
Table 4. Key Players of Chlamydophila-based
Table 5. Key Players of Viral Pneumonia-based
Table 6. Key Players of Mycoplasma Pneumonia-based
Table 7. Global Pneumonia Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Pneumonia Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Pneumonia Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Pneumonia Diagnostic Market Share by Region (2018-2023)
Table 11. Global Pneumonia Diagnostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Pneumonia Diagnostic Market Share by Region (2024-2033)
Table 13. Pneumonia Diagnostic Market Trends
Table 14. Pneumonia Diagnostic Market Drivers
Table 15. Pneumonia Diagnostic Market Challenges
Table 16. Pneumonia Diagnostic Market Restraints
Table 17. Global Pneumonia Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Pneumonia Diagnostic Market Share by Players (2018-2023)
Table 19. Global Top Pneumonia Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Diagnostic as of 2022)
Table 20. Ranking of Global Top Pneumonia Diagnostic Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Pneumonia Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pneumonia Diagnostic Product Solution and Service
Table 24. Date of Enter into Pneumonia Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pneumonia Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Pneumonia Diagnostic Revenue Market Share by Type (2018-2023)
Table 28. Global Pneumonia Diagnostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Pneumonia Diagnostic Revenue Market Share by Type (2024-2033)
Table 30. Global Pneumonia Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Pneumonia Diagnostic Revenue Market Share by Application (2018-2023)
Table 32. Global Pneumonia Diagnostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Pneumonia Diagnostic Revenue Market Share by Application (2024-2033)
Table 34. North America Pneumonia Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Pneumonia Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Pneumonia Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Pneumonia Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Pneumonia Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Pneumonia Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Pneumonia Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Pneumonia Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Pneumonia Diagnostic Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Pneumonia Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Pneumonia Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Pneumonia Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Pneumonia Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Pneumonia Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Pneumonia Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 49. Abbott Company Detail
Table 50. Abbott Business Overview
Table 51. Abbott Pneumonia Diagnostic Product
Table 52. Abbott Revenue in Pneumonia Diagnostic Business (2018-2023) & (US$ Million)
Table 53. Abbott Recent Development
Table 54. Glaxo Smith Kline Company Detail
Table 55. Glaxo Smith Kline Business Overview
Table 56. Glaxo Smith Kline Pneumonia Diagnostic Product
Table 57. Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2018-2023) & (US$ Million)
Table 58. Glaxo Smith Kline Recent Development
Table 59. Affymetrix Company Detail
Table 60. Affymetrix Business Overview
Table 61. Affymetrix Pneumonia Diagnostic Product
Table 62. Affymetrix Revenue in Pneumonia Diagnostic Business (2018-2023) & (US$ Million)
Table 63. Affymetrix Recent Development
Table 64. Becton Dickinson Company Detail
Table 65. Becton Dickinson Business Overview
Table 66. Becton Dickinson Pneumonia Diagnostic Product
Table 67. Becton Dickinson Revenue in Pneumonia Diagnostic Business (2018-2023) & (US$ Million)
Table 68. Becton Dickinson Recent Development
Table 69. BioMerieux Company Detail
Table 70. BioMerieux Business Overview
Table 71. BioMerieux Pneumonia Diagnostic Product
Table 72. BioMerieux Revenue in Pneumonia Diagnostic Business (2018-2023) & (US$ Million)
Table 73. BioMerieux Recent Development
Table 74. Cepheid Company Detail
Table 75. Cepheid Business Overview
Table 76. Cepheid Pneumonia Diagnostic Product
Table 77. Cepheid Revenue in Pneumonia Diagnostic Business (2018-2023) & (US$ Million)
Table 78. Cepheid Recent Development
Table 79. Diamedix/Erba Company Detail
Table 80. Diamedix/Erba Business Overview
Table 81. Diamedix/Erba Pneumonia Diagnostic Product
Table 82. Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2018-2023) & (US$ Million)
Table 83. Diamedix/Erba Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Diagnostic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Pneumonia Diagnostic Market Share by Type: 2022 VS 2033
Figure 3. Streptococcus-based Features
Figure 4. Legionella-based Features
Figure 5. Chlamydophila-based Features
Figure 6. Viral Pneumonia-based Features
Figure 7. Mycoplasma Pneumonia-based Features
Figure 8. Global Pneumonia Diagnostic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Pneumonia Diagnostic Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Diagnostic Centres Case Studies
Figure 13. Others Case Studies
Figure 14. Pneumonia Diagnostic Report Years Considered
Figure 15. Global Pneumonia Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Pneumonia Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Pneumonia Diagnostic Market Share by Region: 2022 VS 2033
Figure 18. Global Pneumonia Diagnostic Market Share by Players in 2022
Figure 19. Global Top Pneumonia Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Diagnostic as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Pneumonia Diagnostic Revenue in 2022
Figure 21. North America Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Pneumonia Diagnostic Market Share by Country (2018-2033)
Figure 23. United States Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Pneumonia Diagnostic Market Share by Country (2018-2033)
Figure 27. Germany Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Pneumonia Diagnostic Market Share by Region (2018-2033)
Figure 35. China Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Pneumonia Diagnostic Market Share by Country (2018-2033)
Figure 43. Mexico Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Pneumonia Diagnostic Market Share by Country (2018-2033)
Figure 47. Turkey Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Pneumonia Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Pneumonia Diagnostic Business (2018-2023)
Figure 50. Glaxo Smith Kline Revenue Growth Rate in Pneumonia Diagnostic Business (2018-2023)
Figure 51. Affymetrix Revenue Growth Rate in Pneumonia Diagnostic Business (2018-2023)
Figure 52. Becton Dickinson Revenue Growth Rate in Pneumonia Diagnostic Business (2018-2023)
Figure 53. BioMerieux Revenue Growth Rate in Pneumonia Diagnostic Business (2018-2023)
Figure 54. Cepheid Revenue Growth Rate in Pneumonia Diagnostic Business (2018-2023)
Figure 55. Diamedix/Erba Revenue Growth Rate in Pneumonia Diagnostic Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed